| Talks： |
OSA and Cardiometabolic Outcomes: Predicting Diabetes and MACE for Precision Treatment
睡眠呼吸中止症與心血管代謝結局：從糖尿病與 MACE 風險預測到精準治療 |
| Name： |
| 林以志（Yi-Chih Lin） |
| Position： |
1. Director, Sleep Center
2. Attending Physician, Department of Otolaryngology–Head and Neck Surgery
|
| Affiliation： |
| Shuang Ho Hospital, Taipei Medical University, Taiwan |
| Email： |
|
| Photo： |
 |
| Research Interests： |
| Obstructive sleep apnea; cardiometabolic outcomes of sleep-disordered breathing; sleep surgery and treatment outcomes; precision risk stratification; artificial intelligence and digital health in sleep medicine. |
| Selected Publications： |
1. Lin YC, Chen CT, Chao PZ, et al. Prevention of Incident Hypertension in Patients With Obstructive Sleep Apnea Treated With Uvulopalatopharyngoplasty or Continuous Positive Airway Pressure: A Cohort Study. Front Surg. 2022;9:818591.
2. Chen YY, Chien R, Lin YC, et al. Assessing cardiac function in obstructive sleep apnea using a novel metric: integrating the respiratory event frequency and desaturation duration. BMC Pulm Med. 2025;25:520.
3. Lee KT, Liu WT, Lin YC, et al. Utilizing a Wireless Radar Framework in Combination With Deep Learning Approaches to Evaluate Obstructive Sleep Apnea Severity in Home-Setting Environments. J Multidiscip Healthc. 2025:381–393.
|
| Abstract： |
Obstructive sleep apnea (OSA) is associated with increased risks of diabetes mellitus (DM) and major adverse cardiovascular events (MACE). However, AHI alone may not adequately reflect individual risk. This presentation will review whether sleep-study parameters beyond AHI—including oxygen desaturation index, mean and minimum oxygen saturation, T90, REM-related events, hypoxic burden, and heart-rate responses—can improve prediction of future DM and cardiovascular events.
The second part will compare the effects of different OSA treatment strategies, including CPAP, sleep surgery, and pharmacologic weight-management therapy such as tirzepatide, with emphasis on their impact on cardiometabolic outcomes. Integrating risk prediction with treatment effectiveness may help move OSA management toward more individualized prevention of DM and MACE.
|
| 2026年會： |
|
|